echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > WuXi Giant Nuo announces approval of JWCAR129 clinical trial application

    WuXi Giant Nuo announces approval of JWCAR129 clinical trial application

    • Last Update: 2021-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Shanghai, September 27, 2021/PRNewswire/ - WuXi Giant Nuo (HKEx code: 2126), an innovative biotechnology company focused on the development, production and commercialization of cellular immunotherapy products, today announced its The application for a clinical trial targeting BCMA chimeric antigen receptor (CAR) T cell JWCAR129 for the treatment of relapsed/refractory multiple myeloma has been approved by the National Medical Products Administration (NMPA) of China


    Multiple myeloma (MM) is an incurable hematological tumor that starts in the bone marrow and is characterized by excessive proliferation of plasma cells


    references:

    1.


    2.


    3.


    4.


    About WuXi Giant Nuo

    WuXi Giant Nuo (HKEx code: 2126) is an innovative biotechnology company focusing on the development, production and commercialization of cellular immunotherapy products


    Forward-looking statement

    The forward-looking statements contained in this release are based on management’s current expectations and confidence, and there are certain uncertainties or risks that may cause actual results to be substantially different from those described


    Source: WuXi Juno

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.